Elisavet Chorafa
Overview
Explore the profile of Elisavet Chorafa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
68
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chorafa E, Iosifidis E, Oletto A, Warris A, Castagnola E, Bruggemann R, et al.
Pediatr Infect Dis J
. 2024 Jun;
43(11):1047-1048.
PMID: 38917027
Background: Data on antifungal prescribing in neonatal patients are limited to either single-center or single-country studies or to 1-day recording. Therefore, we assessed antifungal longitudinal usage in neonatal units (NUs)...
2.
Kourti M, Chorafa E, Roilides E, Iosifidis E
Pediatr Infect Dis J
. 2023 May;
42(7):e246-e248.
PMID: 37257114
No abstract available.
3.
Riddell A, Cook A, Khavessian N, Ellis S, Bilardi D, Correia E, et al.
Antibiotics (Basel)
. 2023 May;
12(5).
PMID: 37237826
Neonatal sepsis is a significant cause of mortality and morbidity in low- and middle-income countries. To deliver high-quality data studies and inform future trials, it is crucial to understand the...
4.
Cook A, Ferreras-Antolin L, Adhisivam B, Ballot D, Berkley J, Bernaschi P, et al.
Med Mycol
. 2023 Mar;
61(3).
PMID: 36881725
Neonatal invasive candidiasis (NIC) has significant morbidity and mortality. Reports have shown a different profile of those neonates affected with NIC and of fluconazole-resistant Candida spp. isolates in low- and...
5.
Chorafa E, Komatsiouli V, Iosifidis E, Kourti M, Sdougka M, Roilides E
Pediatr Crit Care Med
. 2022 Aug;
24(1):e20-e27.
PMID: 36000864
Objectives: Development of antimicrobial stewardship programs (ASPs) is strategy for prevention and management of emergence of antimicrobial-resistant organisms. In this study, we systematically reviewed the literature on antimicrobial stewardship interventions...
6.
Ziaka M, Papakonstantinou E, Vasileiou E, Chorafa E, Antachopoulos C, Roilides E
Mycoses
. 2022 May;
65(7):674-682.
PMID: 35514044
Background: Mucormycosis has emerged as an increasingly important fungal disease for immunocompromised children and neonates, with the cutaneous form being one of its most common presentations. Methods: We present a...
7.
Papakyritsi D, Iosifidis E, Kalamitsou S, Chorafa E, Volakli E, Pena-Lopez Y, et al.
Infect Control Hosp Epidemiol
. 2022 May;
44(2):216-221.
PMID: 35506391
Objective: Ventilator-associated pneumonia (VAP) is one of the most common healthcare-associated infections in pediatric intensive care units (PICUs), but its definite diagnosis remains controversial. The CDC Ventilator-Associated Event (VAE) module...
8.
Kopsidas I, Tsopela G, Molocha N, Bouza E, Chorafa E, Chorianopoulou E, et al.
Antibiotics (Basel)
. 2021 Apr;
10(3).
PMID: 33803250
Antibiotics are commonly prescribed in Neonatal Intensive Care Units (NICU), where stewardship interventions are challenging. Lowering antibiotic consumption is desperately needed in Greece, a country with high antibiotic resistance rates....
9.
Chorafa E, Iosifidis E, Tsiodras S, Skoutelis A, Kourkouni E, Kopsidas I, et al.
Infect Control Hosp Epidemiol
. 2020 Nov;
42(6):702-709.
PMID: 33198846
Objective: To audit clinical practice and implement an intervention to promote appropriate use of perioperative antimicrobial prophylaxis (PAP). Design: Prospective multicenter before-and-after study. Setting: This study was conducted in 7...
10.
Iosifidis E, Chorafa E, Agakidou E, Kontou A, Violaki A, Volakli E, et al.
Pediatr Infect Dis J
. 2019 May;
38(8):812-815.
PMID: 31135647
Background: Emergence of extensively drug-resistant (XDR) or pan drug-resistant (PDR) Enterobacteriaceae is a major public threat especially for young patients. Treatment options for these bacteria are extremely limited with no...